Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
molecular diagnostics
MedTech
DNA test maker BillionToOne raises $314M in IPO, shares dip
BillionToOne raised $314 million in the DNA test maker’s upsized initial public offering but saw share values slide after the first day of trading.
Joseph Keenan
Nov 10, 2025 8:45am
Labcorp launches bird flu test amid first severe case in the US
Dec 18, 2024 3:00pm
Cepheid taps former Philips exec as president
May 24, 2023 10:20am
JPM23: What testmakers like Freenome are taking away from COVID
Jan 10, 2023 10:10am
FDA clears BD's newest molecular diagnostics machine
May 13, 2022 10:10am
Hologic caps off year of European expansion with new French HQ
Mar 24, 2022 1:05pm
